Clinical Trials Browser

NCT02419495 2025-06-04

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

BreastDermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT06839105 2025-05-31

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

Phase 1 Recruiting

214 enrolled

DermatologicGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Colorectal Neoplasms

NCT01676649 2021-02-18

Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Phase 2 Active not recruiting

30 enrolled

Dermatologic

Melanoma

NCT02617849 2021-02-18

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

Phase 2 Unknown

30 enrolled

Dermatologic

Melanoma

NCT00404235 2018-10-16

Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

76 enrolled 10 charts

Dermatologic

Melanoma

NCT01174238 2018-06-08

A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma

Phase 2 Completed

40 enrolled 10 charts

Dermatologic

Melanoma

NCT00626405 2018-05-01

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

Phase 2 Completed

95 enrolled 8 charts

Dermatologic

Melanoma

NCT01009515 2017-10-18

Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Phase 2 Terminated

19 enrolled 11 charts

Dermatologic

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT02023710 2017-05-09

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Phase 2 Unknown

182 enrolled

Dermatologic

Melanoma

NCT00976573 2017-04-04

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

149 enrolled 9 charts

Dermatologic

Melanoma

NCT01200342 2016-02-11

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Phase 2 Terminated

7 enrolled 3 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT00568451 2015-12-30

Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma

Phase 2 Terminated

12 enrolled 9 charts

Dermatologic

Melanoma

NCT00002854 2015-08-26

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Phase 1 Completed

33 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Anus Neoplasms, Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Wilms Tumor, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT01014351 2014-03-26

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Phase 2 Completed

70 enrolled 8 charts

Dermatologic

Melanoma

NCT00003690 2011-08-03

Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

48 enrolled

BreastDermatologicGenitourinary

Breast Neoplasms, Melanoma, Prostatic Neoplasms